@csrwin
Thanks for the link.
Points I noticed.
* the main reason that XanaHES didn't continue to 30mg was because full target occupancy was achieved at 20mg
* funding of future studies wasn't discussed. Nor should it have been; this was a purely scientific presentation
* although the target occupancy study doesn't complete until Q2, 20mg has already been chosen for MCI
* at about 14:00 a toilet flushing noise can be distinctly heard. No dogs barking or babies crying that I noticed. YMMV.
GLTALTH and please keep washing your hands for the foreseeable future
II
Ann: Actinogen presents latest Xanamem data at AD Conference, page-26
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
-0.003(7.69%) |
Mkt cap ! $97.64M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.9¢ | 3.6¢ | $151.2K | 4.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 3271718 | 3.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 125725 | 3 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |